Vaccination Coverage with the Pneumococcal and Influenza Vaccine Among Persons with Chronic Diseases in Shanghai, China, 2017
Authors:
Preprint
- 10 February 2020
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: Adults with chronic conditions such as heart disease, diabetes, or lung disease are more likely to develop complications from a number of vaccine-preventable diseases, including influenza and pneumonia. In this study, we use the data from a chronic disease management information system in Shanghai to estimate vaccination coverage and characterize predictors of seasonal influenza and 23-valent pneumococcal polysaccharide vaccine (PPSV23) vaccination among people with chronic disease in Shanghai.Methods: The Shanghai Centers for Disease Control and Prevention have information systems related to chronic disease management, hospital records, and immunizations. Data from individuals with hypertension, diabetes and chronic obstructive pulmonary disease (COPD) were abstracted during July 2017. The main outcome was coverage of pneumococcal and influenza vaccination. Vaccination coverage was calculated across demographic groups. Significance in bivariate associations was assessed through Pearson’s chi-square tests, and in multivariable models through logistic regression models with a forward stepwise method to select variables.Results: In the sample of 2,531,227 individuals ≥15 years, 22.8% were vaccinated for pneumonia from January 2013 to July 2017, and the vaccination coverage of influenza in the 2016/17 influenza season was 0.4%. Vaccination coverage was highest in those 70-79 and lowest in those younger than 60. Compared to urban areas, uptake in rural areas was higher for pneumonia vaccination (OR: 2.43, 95% CI: 2.41, 2.45), but lower for influenza vaccination (OR: 0.55, 95% CI: 0.51, 0.59). Having a greater number of chronic diseases was associated with higher likelihood of pneumonia vaccination (3 vs 1: OR: 1.68, 95% CI: 1.64, 1.71), but this relationship was not statistically significant for influenza vaccination.Conclusions: We found low levels with of pneumococcal vaccination, and extremely low uptake of influenza vaccination among individuals with high risk conditions in Shanghai who should be priority groups targeted for vaccination. Interventions could be designed to target groups with low uptake – like younger adults, and individuals who have not yet retired.Keywords
All Related Versions
- Published version: BMC Public Health, 20 (1), 1.
This publication has 30 references indexed in Scilit:
- China's vaccine production scareThe Lancet, 2018
- Seasonal influenza vaccination in China: Landscape of diverse regional reimbursement policy, and budget impact analysisVaccine, 2016
- Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysisHuman Vaccines & Immunotherapeutics, 2016
- The free vaccination policy of influenza in Beijing, China: The vaccine coverage and its associated factorsVaccine, 2016
- Technical guidelines for the application of seasonal influenza vaccine in China (2014–2015)Human Vaccines & Immunotherapeutics, 2015
- Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011–2012: Hospital-based Influenza Morbidity & Mortality (HIMM) surveillanceJournal of Infection and Chemotherapy, 2014
- Additive benefits of pneumococcal and influenza vaccines among elderly persons aged 75 years or older in Taiwan – A representative population-based comparative studyJournal of Infection, 2012
- Vaccination coverage rates in eleven European countries during two consecutive influenza seasonsJournal of Infection, 2009
- Influenza Vaccination of Elderly PersonsJAMA, 1980